Sheryl Kingsberg, PhD
- Division Chief, OB/GYN Behavioral Medicine, UH Cleveland Medical Center
- Co-Director, Sexual Medicine and Vulvovaginal Health Program, UH Cleveland Medical Center
- Professor of Obstetrics and Gynecology, CWRU School of Medicine
- Professor of Psychiatry, CWRU School of Medicine
- Specialty: Psychology-Adult Psychology
-
Location:UH MacDonald Risman Pavilion
1000 Auburn Dr
Beachwood, OH 44122
- Call: 216-285-5028
Biography: Sheryl Kingsberg, PhD
Expertise
Education
Post Doctorate Training | Psychology
Psychology - University Hospitals Of Cleveland (1989 - 1991)
Professional Education
University Of South Florida (1989)
Professional Education
University Of South Florida (1986)
Undergraduate
Smith College (1984)
About
Dr. Sheryl Kingsberg is the Division Chief of Behavioral Medicine at University Hospitals MacDonald Women’s Hospital and Professor in Reproductive Biology, Urology and Psychiatry at Case Western Reserve University. Her areas of clinical specialization include female sexual disorders, menopause, pregnancy and postpartum mood disorders, and psychological aspects of infertility.
Dr. Kingsberg’s primary research interests are in treatments for female sexual disorders, genitourinary syndrome of menopause (GSM) and reproductive mental health. She is an Associate Editor for Sexual Medicine Reviews and sits on the editorial boards of the journals Menopause and Climacteric. She has over 100 peer-reviewed publications and numerous book chapters and has co-edited a multidisciplinary textbook on treating female sexual disorders.
Dr. Kingsberg is a past president of The Menopause Society and The International Society for the Study of Women’s Sexual Health. She currently serves as the Advocacy Committee Chair for both of these organizations.
Research & Publications
Research Interests
- Postpartum Depression
- Cognitive Behavioral Therapy (CBT)
- Psychological Aspects of Cancer
- Psychologic Aspects of Infertility
- Sexual Dysfunction - Female
Featured Videos
Watch to find out more about this University Hospitals physician.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Sheryl Kingsberg disclosed the following Outside Relationships with Industry:
- - BioSante Pharmaceuticals - Consulting
- - Trimel Pharmaceutical - Consulting
- - Viveve - Ownership
- - AMAG - Consulting payments
- - Palatin - Consulting payments
- - Pfizer, Inc. - Consulting payments
- - TherapeuticsMD - Consulting payments